NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

Enrolling By InvitationNA

Sponsor: University of California, Los Angeles

Conditions: Virus Infection, RNA

Interventions: GenX intergenerational mentoring program

Countries: United States

This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.

Eligibility overview

Sex: ALL

Age: 50 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Participating in the GenX intergenerational mentoring program
* All GenX mentors \> 50 years of age are eligible to participate in this research
* GenX program participation requires:
* Reside in neighborhood of GenX schools (South-Central Los Angeles)
* Pass basic literacy and cognitive function tests

Exclusion Criteria:

* Any health condition that would put participant at risk by enrollment/participation

Locations (1)

Los Angeles, California, United States